iwNHL 2018

The 16th International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place in Nice, France, from September 21–23, 2018.

This year’s meeting highlighted efforts to understand the biology of different NHL subtypes, as well as novel therapeutic strategies to optimize clinical care.

As the iwNHL’s official media partner, VJHemOnc was there to cover this exciting new content.

The challenging field of hem-onc therapeutics

Non-hodgkin lymphoma advances in 2018

CAR-T super users: teams to closely monitor patients receiving CAR T-cells

Bianca Santomasso

Nuances of systemic lymphoma and CNS lymphoma

Bianca Santomasso

CAR T-cell therapy: on the way to success

Management of cytokine release syndrome and neurotoxicity: an emerging need

Bianca Santomasso

Viral lymphomas: risk factors and treatments

Catherine Bollard et al.

Pathobiology and clinical management of T-cell lymphoma

Francine Foss et al.

Cellular therapy and drug access for viral lymphomas

Catherine Bollard et al.

Precision medicine in lymphoma

Anas Younes et al.

Novel diagnostics & biomarkers for DLBCL and CTCL

Bjoern Chapuy et al.

Immunotherapy for NHL: checkpoint inhibitors, considerations & the future

John Gribben et al.

iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine

Anas Younes et al.

iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine

Catherine Bollard et al.

Novel targets and agents for lymphoma

John Kuruvilla et al.

CAR T-cells in lymphoma: where are we now?

David Maloney et al.